Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Clinical trial NCT05948475 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05948475
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2026-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.